333 related articles for article (PubMed ID: 1906023)
1. The effect of aldose reductase inhibitors on glomerular prostaglandin production and urinary albumin excretion in experimental diabetes mellitus.
Chang WP; Dimitriadis E; Allen T; Dunlop ME; Cooper M; Larkins RG
Diabetologia; 1991 Apr; 34(4):225-31. PubMed ID: 1906023
[TBL] [Abstract][Full Text] [Related]
2. Sorbinil suppresses glomerular prostaglandin production in the streptozotocin diabetic rat.
Craven PA; DeRubertis FR
Metabolism; 1989 Jul; 38(7):649-54. PubMed ID: 2500578
[TBL] [Abstract][Full Text] [Related]
3. Prevention of hemodynamic and vascular albumin filtration changes in diabetic rats by aldose reductase inhibitors.
Tilton RG; Chang K; Pugliese G; Eades DM; Province MA; Sherman WR; Kilo C; Williamson JR
Diabetes; 1989 Oct; 38(10):1258-70. PubMed ID: 2507378
[TBL] [Abstract][Full Text] [Related]
4. Discordant effects of the aldose reductase inhibitor, sorbinil, on vascular structure and function in chronically diabetic and galactosemic rats.
Tilton RG; Pugliese G; LaRose LS; Faller AM; Chang K; Province MA; Williamson JR
J Diabet Complications; 1991; 5(4):230-7. PubMed ID: 1779018
[TBL] [Abstract][Full Text] [Related]
5. Sorbinil does not prevent hyperfiltration, elevated ultrafiltration pressure and albuminuria in streptozotocin-diabetic rats.
Körner A; Celsi G; Eklöf AC; Linné T; Persson B; Aperia A
Diabetologia; 1992 May; 35(5):414-8. PubMed ID: 1521721
[TBL] [Abstract][Full Text] [Related]
6. Short term effect of an aldose reductase inhibitor on urinary albumin excretion rate (UAER) and glomerular filtration rate (GFR) in type 1 diabetic patients with incipient nephropathy.
Ranganathan S; Krempf M; Feraille E; Charbonnel B
Diabete Metab; 1993; 19(2):257-61. PubMed ID: 8339858
[TBL] [Abstract][Full Text] [Related]
7. Comparison of sorbinil and ponalrestat (Statil) diminution of proteinuria in the BB rat.
Beyer-Mears A; Murray FT; Cruz E; Rountree J; Sciadini M
Pharmacology; 1992; 45(5):285-91. PubMed ID: 1465475
[TBL] [Abstract][Full Text] [Related]
8. Effects of sorbinil on glomerular structure and function in long-term-diabetic rats.
Mauer SM; Steffes MW; Azar S; Brown DM
Diabetes; 1989 Jul; 38(7):839-46. PubMed ID: 2525493
[TBL] [Abstract][Full Text] [Related]
9. Sorbinil prevents glomerular hyperperfusion in diabetic rats.
Bank N; Mower P; Aynedjian HS; Wilkes BM; Silverman S
Am J Physiol; 1989 Jun; 256(6 Pt 2):F1000-6. PubMed ID: 2500028
[TBL] [Abstract][Full Text] [Related]
10. Glomerular polyol accumulation in diabetes and its prevention by oral sorbinil.
Beyer-Mears A; Ku L; Cohen MP
Diabetes; 1984 Jun; 33(6):604-7. PubMed ID: 6427041
[TBL] [Abstract][Full Text] [Related]
11. The relative roles of advanced glycation, oxidation and aldose reductase inhibition in the development of experimental diabetic nephropathy in the Sprague-Dawley rat.
Soulis-Liparota T; Cooper ME; Dunlop M; Jerums G
Diabetologia; 1995 Apr; 38(4):387-94. PubMed ID: 7796978
[TBL] [Abstract][Full Text] [Related]
12. Aldose reductase inhibition by ponalrestat (statil) does not prevent proteinuria in long-term diabetic rats.
Reddi AS; Jyothirmayi GN
J Diabetes Complications; 1993; 7(4):233-40. PubMed ID: 8219366
[TBL] [Abstract][Full Text] [Related]
13. Galactose feeding causes glomerular hyperperfusion: prevention by aldose reductase inhibition.
Bank N; Coco M; Aynedjian HS
Am J Physiol; 1989 Jun; 256(6 Pt 2):F994-9. PubMed ID: 2500030
[TBL] [Abstract][Full Text] [Related]
14. Aldose reductase inhibition and glomerular abnormalities in diabetic rats.
Daniels BS; Hostetter TH
Diabetes; 1989 Aug; 38(8):981-6. PubMed ID: 2502460
[TBL] [Abstract][Full Text] [Related]
15. Aldose reductase and the development of renal disease in diabetic dogs.
Kern TS; Engerman RL
J Diabetes Complications; 1999; 13(1):10-6. PubMed ID: 10232704
[TBL] [Abstract][Full Text] [Related]
16. Renal and microvascular effects of an aldose reductase inhibitor in experimental diabetes. Biochemical, functional and ultrastructural studies.
Kassab JP; Guillot R; Andre J; Claperon N; Bellon G; Feldmann G; Peyroux J; Sternberg M
Biochem Pharmacol; 1994 Aug; 48(5):1003-8. PubMed ID: 8093087
[TBL] [Abstract][Full Text] [Related]
17. Aldose reductase, glomerular metabolism, and diabetic nephropathy.
Cohen MP
Metabolism; 1986 Apr; 35(4 Suppl 1):55-9. PubMed ID: 3007926
[TBL] [Abstract][Full Text] [Related]
18. Effects of polyol-pathway inhibition and dietary myo-inositol on glomerular hemodynamic function in experimental diabetes mellitus in rats.
Goldfarb S; Ziyadeh FN; Kern EF; Simmons DA
Diabetes; 1991 Apr; 40(4):465-71. PubMed ID: 2010046
[TBL] [Abstract][Full Text] [Related]
19. Diminished proteinuria in diabetes mellitus by sorbinil, an aldose reductase inhibitor.
Beyer-Mears A; Cruz E; Edelist T; Varagiannis E
Pharmacology; 1986; 32(1):52-60. PubMed ID: 3080763
[TBL] [Abstract][Full Text] [Related]
20. Effect of diabetes and Sorbinil treatment on phospholipid metabolism in rat glomeruli.
Cohen MP; Klepser H; Cua E
Biochim Biophys Acta; 1986 Apr; 876(2):226-32. PubMed ID: 3006784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
